Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 01, 2009 (Vol. 29, No. 7)

OMICS

URL:omics.org
  • Good potential
  • Potential unrealized as yet
When it comes to Omics, the topic doesn’t get covered better anywhere than at the wiki for the subject maintained by Omics.org. On the page, users will discover everything from definitions of Omics to lists of Omics and Omics projects. A nice figure of various omes is available for free download. The open design of the site actually provides everything for free access, which is a big plus. There are links to numerous Omics biosites, though I discovered that some of them were broken. There are links to conferences and a list (empty, actually) of prominent omists. In general, I’m rather disappointed at the offerings of the site. It seems it should have more connections to active Omics work than it does. While I might be expecting a bit too much (I often do), I think there is significant potential for improvement, and I hope the site’s designers put more content in the pages soon.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »